- Fendler, Wolfgang P;
- Eiber, Matthias;
- Beheshti, Mohsen;
- Bomanji, Jamshed;
- Calais, Jeremie;
- Ceci, Francesco;
- Cho, Steve Y;
- Fanti, Stefano;
- Giesel, Frederik L;
- Goffin, Karolien;
- Haberkorn, Uwe;
- Jacene, Heather;
- Koo, Phillip J;
- Kopka, Klaus;
- Krause, Bernd J;
- Lindenberg, Liza;
- Marcus, Charles;
- Mottaghy, Felix M;
- Oprea-Lager, Daniela E;
- Osborne, Joseph R;
- Piert, Morand;
- Rowe, Steven P;
- Schöder, Heiko;
- Wan, Simon;
- Wester, Hans-Jürgen;
- Hope, Thomas A;
- Herrmann, Ken
Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.
